\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ unrevealing\\ with\\ normal\\ lung\\ exam\\ and\\ no\\ adenopathy\\ or\\ palpable\\ chest\\ wall\\ mass\\ appreciated\\.\ \(0\)\
\-\ laboratory\\ examinations\\ were\\ \\ normal\\ except\\ for\\ the\\ \\ esr\\ which\\ was\\ raised\\ 40\\/90\\.\ \(0\)\
\-\ the\\ patient\\ currently\\ is\\ undergoing\\ combination\\ therapy\\ with\\ 3\\ cycles\\ of\\ chemotherapy\\ with\\ cyclophosphamide\\,\\ vincristine\\,\\ and\\ adriamycin\\.\ \(0\)\
\-\ chest\\ radiograph\\ revealed\\ a\\ 2cm\\ parietal\\-based\\ mass\\ in\\ the\\ lateral\\ side\\ of\\ right\\ hemi\\ thorax\\,\\ at\\ the\\ level\\ of\\ the\\ middle\\ arch\\ of\\ the\\ third\\ right\\ rib\\.\\ \\ \ \(0\)\
\-\ four\\ months\\ later\\ the\\ chest\\ plain\\ films\\ demontrates\\ a\\ 7\\ cm\\ lobulated\\ parietal\\-based\\ opacity\\ centered\\ on\\ the\\ middle\\ arch\\ of\\ the\\ third\\ right\\ rib\\ with\\ cortical\\ rupture\\ and\\ bone\\ destruction\\ of\\ the\\ affected\\ area\\ of\\ the\\ rib\\.\ \(0\)\
\-\ thoraco\\ abdomino\\ pelvic\\ contrast\\-enhanced\\ computed\\ tomography\\ \\(ct\\)\\ revealed\\ an\\ 8\\ x\\ 7\\ centimeter\\ right\\ lateral\\ chest\\ wall\\ mass\\ with\\ expansion\\,\\ destruction\\ and\\ cortical\\ spread\\ out\\ of\\ the\\ middle\\ arch\\ of\\ the\\ right\\ third\\ rib\\.\\ this\\ parietal\\ mass\\ \\ \\ was\\ \\ \\ spontaneously\\ \\ \\ heterogeneous\\ containing\\ solid\\ and\\ necrotic\\ areas\\ and\\ demonstrates\\ intense\\ contrast\\ uptake\\ in\\ the\\ solid\\ portion\\ \\ \\ after\\ injection\\ \\.\ \(0\)\
\-\ metastic\\ lesions\\ were\\ identified\\ \\ at\\ l5\\ vertebral\\ body\\ with\\ extension\\ to\\ the\\ epidural\\,\\ in\\ the\\ \\ lower\\ lobe\\ of\\ left\\ lung\\ and\\ in\\ the\\ left\\ iliac\\ wing\\.\ \(0\)\
\-\ askin\\ tumor\\ of\\ chest\\ wall\ \(0\)\
\-\ aside\\ the\\ possibility\\ of\\ askin\\ tumor\\,\\ the\\ differential\\ diagnosis\\ in\\ case\\ of\\ aggressive\\ rapidly\\ growing\\ chest\\ wall\\ mass\\ could\\ be\\ an\\ ewing\\ sarcoma\\ a\\ lymphoma\\,\\ osteosarcoma\\,\\ fibro\\ sarcoma\\,\\ reticulum\\ cell\\ sarcoma\\,\\ histiocytosis\\ x\\,\\ bone\\ metastases\\,\\ sub\\ acute\\ or\\ chronic\\ osteomyelitis\\.\ \(0\)\
\-\ a\\ 31\\-year\\-old\\ male\\ without\\ significant\\ past\\ medical\\ history\\ presented\\ to\\ the\\ emergency\\ department\\ at\\ our\\ institution\\ with\\ a\\ 1\\ week\\ history\\ of\\ fevers\\ and\\ \\ right\\-sided\\ pleuritic\\ chest\\ pain\\.\\ additional\\ history\\ revealed\\ \\ \\ night\\ sweats\\ over\\ the\\ previous\\ month\\,\\ and\\ a\\ 10\\-pound\\ weight\\ loss\\ over\\ the\\ two\\ preceding\\ months\\.\ \(0\)\
\-\ primitive\\ neuroectodermal\\ tumors\\ of\\ the\\ chest\\ wall\\,\\ also\\ called\\ \\"askin\\ tumors\\,\\"\\ are\\ rare\\,\\ highly\\ malignant\\ tumors\\ that\\ have\\ traditionally\\ been\\ felt\\ to\\ occur\\ only\\ in\\ the\\ pediatric\\ or\\ young\\ adult\\ population\\.\\ these\\ tumors\\ are\\ often\\ very\\ large\\ at\\ the\\ time\\ of\\ diagnosis\\.\\ the\\ most\\ common\\ manifestation\\ of\\ these\\ tumors\\ includes\\ pain\\ from\\ mass\\ effect\\,\\ often\\ of\\ several\\ months\\ duration\\.\\ additional\\ symptoms\\ include\\ progressive\\ shortness\\ of\\ breath\\ and\\ dyspnea\\,\\ fever\\,\\ night\\ sweats\\,\\ and\\ weight\\ loss\\.\\ for\\ our\\ patient\\ the\\ age\\ was\\ unusual\\ \\(36\\ years\\)\\ and\\ the\\ clinical\\ manifestation\\ was\\ right\\ chest\\ wall\\ pain\\ and\\ fever\\ and\\ weight\\ loss\\ \\ \\ with\\ 3\\ months\\ later\\ low\\ back\\ pain\\ due\\ to\\ the\\ secondary\\ location\\ in\\ the\\ lumbar\\ spine\\ and\\ subsequent\\ epidural\\ invasion\\.\\ \ \(0\)\
\-\ \\ radiographic\\ studies\\ are\\ non\\-specific\\,\\ but\\ most\\ often\\ reveal\\ a\\ chest\\ wall\\ mass\\ with\\ local\\ rib\\ destruction\\ and\\ extension\\ into\\ the\\ thoracic\\ cavity\\.\\ \ \(0\)\
\-\ in\\ the\\ primary\\ lesion\\ evaluation\\,\\ the\\ priority\\ is\\ to\\ obtain\\ imaging\\ studies\\ of\\ the\\ suspected\\ primary\\ lesion\\ or\\ region\\ with\\ symptoms\\.\\ if\\ a\\ bony\\ mass\\ is\\ palpated\\,\\ plain\\ radiography\\ is\\ indicated\\.\\ ct\\ scan\\ and\\ better\\ mri\\ of\\ the\\ region\\ can\\ help\\ to\\ identify\\ the\\ extent\\ of\\ disease\\.\ \(0\)\
\-\ ct\\ imaging\\ is\\ helpful\\ to\\ delineate\\ any\\ bony\\ involvement\\.\\ \ \(0\)\
\-\ tumors\\ that\\ are\\ adjacent\\ to\\ critical\\ neurological\\ structures\\ require\\ immediate\\ mri\\ scanning\\ and\\ consideration\\ of\\ emergent\\ radiation\\ therapy\\ to\\ prevent\\ nerve\\ damage\\.\\ magnetic\\ resonance\\ imaging\\ often\\ allows\\ more\\ accurate\\ delineation\\ and\\ localization\\ of\\ the\\ tumor\\ and\\ is\\ helpful\\ for\\ determining\\ the\\ presence\\ and\\ extent\\ of\\ tumor\\ invasion\\ and\\ for\\ tissue\\ characterization\\.\ \(0\)\
\-\ \\ metastatic\\ evaluation\\ includes\\ chest\\ ct\\ scanning\\ and\\ radioisotope\\ bone\\ scanning\\.\\ if\\ a\\ tumor\\ is\\ likely\\ based\\ on\\ initial\\ study\\ results\\,\\ the\\ chest\\ ct\\ scan\\ is\\ best\\ obtained\\ prior\\ to\\ surgical\\ biopsy\\ to\\ avoid\\ confusion\\ with\\ postoperative\\ atelectasis\\.\\ metastases\\ to\\ both\\ pulmonary\\ and\\ extra\\-pulmonary\\ sites\\ are\\ common\\.\\ in\\ our\\ case\\ at\\ least\\ three\\ secondary\\ locations\\ were\\ noted\\ in\\ the\\ left\\ lung\\,\\ in\\ the\\ left\\ iliac\\ bone\\ and\\ in\\ \\ the\\ lumbar\\ spine\\ with\\ epidural\\ invasion\\ \\.\ \(0\)\
\-\ no\\ pathognomonic\\ or\\ suggestive\\ blood\\ studies\\ can\\ be\\ used\\ to\\ diagnose\\ askin\\â\\€\\™s\\ tumor\\.\\ depending\\ on\\ the\\ patient\\â\\€\\™s\\ age\\ and\\ presenting\\ symptoms\\,\\ blood\\ tests\\,\\ including\\ erythrocyte\\ sedimentation\\ rate\\,\\ c\\-reactive\\ protein\\,\\ blood\\ culture\\,\\ and\\ complete\\ blood\\ cell\\ count\\,\\ might\\ be\\ helpful\\ when\\ considering\\ other\\ diagnoses\\.\ \(0\)\
\-\ the\\ typical\\ histological\\ features\\ include\\ uniform\\ sheets\\ of\\ round\\,\\ blue\\ cells\\ with\\ round\\ nuclei\\,\\ sparse\\ cytoplasm\\,\\ a\\ high\\ mitotic\\ index\\,\\ and\\ homer\\-wright\\ pseudo\\-rosette\\ formation\\,\\ immunohistochemical\\ staining\\ most\\ commonly\\ reveals\\ staining\\ for\\ neuron\\-specific\\ enolase\\ \\(nse\\)\\ and\\ vimentine\\,\\ both\\ of\\ which\\ were\\ positive\\ in\\ this\\ case\\.\\ \\ \\ pnets\\ also\\ have\\ a\\ cytogenetic\\ translocation\\,\\ t\\ \\(11\\;\\ 22\\)\\(q24\\;\\ q12\\)\\ that\\ is\\ shared\\ with\\ ewing\\'s\\ sarcoma\\,\\ and\\ occurs\\ in\\ approximately\\ 90\\%\\ of\\ the\\ ewing\\'s\\-\\-pnets\\ that\\ can\\ be\\ evaluated\\,\\ suggesting\\ a\\ common\\ origin\\.\\ \\ \\ this\\ genetic\\ abnormality\\ was\\ not\\ checked\\ in\\ this\\ patient\\.\ \(0\)\
\-\ aside\\ the\\ possibility\\ of\\ askin\\ tumor\\,\\ the\\ differential\\ diagnosis\\ in\\ case\\ of\\ aggressive\\ rapidly\\ growing\\ chest\\ wall\\ mass\\ could\\ be\\ an\\ ewing\\ sarcoma\\ a\\ lymphoma\\,\\ osteosarcoma\\,\\ fibro\\ sarcoma\\,\\ reticulum\\ cell\\ sarcoma\\,\\ histiocytosis\\ x\\,\\ bone\\ metastases\\,\\ sub\\ acute\\ or\\ chronic\\ osteomyelitis\\.\ \(0\)\
\-\ the\\ radiographic\\ findings\\ are\\ not\\ specific\\ and\\ are\\ the\\ same\\ \\ \\ radiological\\ features\\ in\\ many\\ other\\ malignant\\ chest\\ wall\\ tumors\\ such\\ as\\ ewing\\ sarcoma\\,\\ lymphoma\\ and\\ metastasis\\ however\\ knowledge\\ of\\ the\\ typical\\ radiological\\ manifestations\\ of\\ these\\ tumors\\ often\\ enables\\ their\\ differentiation\\ from\\ benign\\ chest\\ wall\\ tumors\\.\ \(0\)\
\-\ this\\ patient\\'s\\ presentation\\ was\\ unusual\\ \\ first\\ for\\ the\\ age\\ and\\ second\\ for\\ the\\ short\\ duration\\ of\\ pleuritic\\ chest\\ pain\\ prior\\ to\\ diagnosis\\ and\\ also\\ the\\ appearance\\ of\\ low\\ back\\ pain\\ 3\\ months\\ later\\ that\\ warned\\ us\\ for\\ a\\ secondary\\ metastatic\\ lesion\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ the\\:\\ 0\\.30266659228650244\ \(0\)\
\-\ chest\\:\\ 0\\.24171183086507117\ \(0\)\
\-\ askin\\:\\ 0\\.20128691123373402\ \(0\)\
\-\ and\\:\\ 0\\.20107377938283236\ \(0\)\
\-\ sarcoma\\:\\ 0\\.19206681290632002\ \(0\)\
\-\ of\\:\\ 0\\.19042622797037184\ \(0\)\
\-\ tumors\\:\\ 0\\.18943561543539275\ \(0\)\
\-\ wall\\:\\ 0\\.17409765169121427\ \(0\)\
\-\ ewing\\:\\ 0\\.1543310751396645\ \(0\)\
\-\ rib\\:\\ 0\\.1307099805560707\ \(0\)\
\-\ in\\:\\ 0\\.12103458572700539\ \(0\)\
\-\ tumor\\:\\ 0\\.1047887717427015\ \(0\)\
\-\ to\\:\\ 0\\.100168570684398\ \(0\)\
\-\ mass\\:\\ 0\\.09838805299998123\ \(0\)\
\-\ scanning\\:\\ 0\\.09339101424056924\ \(0\)\
\-\ often\\:\\ 0\\.09337214230910826\ \(0\)\
\-\ reticulum\\:\\ 0\\.09153863425798366\ \(0\)\
\-\ pnets\\:\\ 0\\.09153863425798366\ \(0\)\
\-\ months\\:\\ 0\\.08329524331049742\ \(0\)\
\-\ helpful\\:\\ 0\\.08141298018558768\ \(0\)\
\-\ fibro\\:\\ 0\\.0789679612799746\ \(0\)\
\-\ with\\:\\ 0\\.07845765018667392\ \(0\)\
\-\ destruction\\:\\ 0\\.07827622055036207\ \(0\)\
\-\ bone\\:\\ 0\\.07807931951176533\ \(0\)\
\-\ epidural\\:\\ 0\\.07798108289748512\ \(0\)\
\-\ invasion\\:\\ 0\\.07658642498635392\ \(0\)\
\-\ our\\:\\ 0\\.0760628404370636\ \(0\)\
\-\ are\\:\\ 0\\.07601943117051162\ \(0\)\
\-\ arch\\:\\ 0\\.07283338533221194\ \(0\)\
\-\ is\\:\\ 0\\.07053958071551741\ \(0\)\
\-\ was\\:\\ 0\\.0698200257878082\ \(0\)\
\-\ aside\\:\\ 0\\.06949089472900354\ \(0\)\
\-\ metastases\\:\\ 0\\.06941257796177952\ \(0\)\
\-\ for\\:\\ 0\\.06939557385560075\ \(0\)\
\-\ parietal\\:\\ 0\\.06933010357442111\ \(0\)\
\-\ pleuritic\\:\\ 0\\.06894836483746739\ \(0\)\
\-\ staining\\:\\ 0\\.06660418962566649\ \(0\)\
\-\ blood\\:\\ 0\\.06648518778560555\ \(0\)\
\-\ right\\:\\ 0\\.06642057336052795\ \(0\)\
\-\ third\\:\\ 0\\.06537479236458593\ \(0\)\
\-\ specific\\:\\ 0\\.06506185930417037\ \(0\)\
\-\ manifestation\\:\\ 0\\.06505738641214748\ \(0\)\
\-\ studies\\:\\ 0\\.06298248423021353\ \(0\)\
\-\ based\\:\\ 0\\.06219426550447252\ \(0\)\
\-\ that\\:\\ 0\\.062099635357536626\ \(0\)\
\-\ pain\\:\\ 0\\.061447341534218144\ \(0\)\
\-\ later\\:\\ 0\\.061445278250750024\ \(0\)\
\-\ middle\\:\\ 0\\.061396646421582025\ \(0\)\
\-\ weight\\:\\ 0\\.059874060684194014\ \(0\)\
\-\ or\\:\\ 0\\.059737947261216055\ \(0\)\
\-\ radiological\\:\\ 0\\.05944200086805197\ \(0\)\
\-\ diagnosis\\:\\ 0\\.05934524008379368\ \(0\)\
\-\ were\\:\\ 0\\.05901075371794819\ \(0\)\
\-\ sweats\\:\\ 0\\.058467024964513475\ \(0\)\
\-\ sub\\:\\ 0\\.05810209897823392\ \(0\)\
\-\ be\\:\\ 0\\.05804957697187531\ \(0\)\
\-\ case\\:\\ 0\\.05751313837259961\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.05740979975875913\ \(0\)\
\-\ rapidly\\:\\ 0\\.05724393881410414\ \(0\)\
\-\ revealed\\:\\ 0\\.05629758068547684\ \(0\)\
\-\ growing\\:\\ 0\\.05615386788773302\ \(0\)\
\-\ duration\\:\\ 0\\.05517069732576532\ \(0\)\
\-\ ct\\:\\ 0\\.05447916422893687\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.05415369004434653\ \(0\)\
\-\ at\\:\\ 0\\.054050335039161616\ \(0\)\
\-\ age\\:\\ 0\\.05390341238450339\ \(0\)\
\-\ possibility\\:\\ 0\\.05323033940843323\ \(0\)\
\-\ iliac\\:\\ 0\\.05269361475783938\ \(0\)\
\-\ extent\\:\\ 0\\.05238484089732586\ \(0\)\
\-\ loss\\:\\ 0\\.05230872333302151\ \(0\)\
\-\ lung\\:\\ 0\\.05222929550736429\ \(0\)\
\-\ night\\:\\ 0\\.051419254307365554\ \(0\)\
\-\ unusual\\:\\ 0\\.05132761569157152\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05113461859302454\ \(0\)\
\-\ secondary\\:\\ 0\\.050891060883300136\ \(0\)\
\-\ aggressive\\:\\ 0\\.04949813579398881\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.04934724033859387\ \(0\)\
\-\ this\\:\\ 0\\.049171421743229006\ \(0\)\
\-\ cell\\:\\ 0\\.04911556086266865\ \(0\)\
\-\ common\\:\\ 0\\.048692142279601176\ \(0\)\
\-\ these\\:\\ 0\\.048484817541138904\ \(0\)\
\-\ symptoms\\:\\ 0\\.046977427097751066\ \(0\)\
\-\ round\\:\\ 0\\.046900625308487265\ \(0\)\
\-\ patient\\:\\ 0\\.04654294779393719\ \(0\)\
\-\ lumbar\\:\\ 0\\.04622006904961407\ \(0\)\
\-\ features\\:\\ 0\\.04605690515071886\ \(0\)\
\-\ abdomino\\:\\ 0\\.04576931712899183\ \(0\)\
\-\ nse\\:\\ 0\\.04576931712899183\ \(0\)\
\-\ vimentine\\:\\ 0\\.04576931712899183\ \(0\)\
\-\ q24\\:\\ 0\\.04576931712899183\ \(0\)\
\-\ checked\\:\\ 0\\.04576931712899183\ \(0\)\
\-\ 90\\:\\ 0\\.04573832732392581\ \(0\)\
\-\ imaging\\:\\ 0\\.045122046387031274\ \(0\)\
\-\ can\\:\\ 0\\.045056319042264585\ \(0\)\
\-\ most\\:\\ 0\\.04468385746055714\ \(0\)\
\-\ includes\\:\\ 0\\.04451010193719986\ \(0\)\
\-\ additional\\:\\ 0\\.04437232825765797\ \(0\)\
\-\ typical\\:\\ 0\\.044236420644764\ \(0\)\
\-\ bony\\:\\ 0\\.044102329223655715\ \(0\)\
\-\ solid\\:\\ 0\\.043882750249893306\ \(0\)\
\-\ enolase\\:\\ 0\\.04373502596370358\ \(0\)\
\-\ enables\\:\\ 0\\.04373502596370358\ \(0\)\
\-\ warned\\:\\ 0\\.04373502596370358\ \(0\)\
\-\ radiographic\\:\\ 0\\.04246711699163121\ \(0\)\
\-\ thoraco\\:\\ 0\\.04229167341203505\ \(0\)\
\-\ delineation\\:\\ 0\\.04229167341203505\ \(0\)\
\-\ cytogenetic\\:\\ 0\\.04229167341203505\ \(0\)\
\-\ shared\\:\\ 0\\.04229167341203505\ \(0\)\
\-\ could\\:\\ 0\\.04163496381922304\ \(0\)\
\-\ priority\\:\\ 0\\.041172122195538154\ \(0\)\
\-\ radioisotope\\:\\ 0\\.041172122195538154\ \(0\)\
\-\ sparse\\:\\ 0\\.041172122195538154\ \(0\)\
\-\ translocation\\:\\ 0\\.041172122195538154\ \(0\)\
\-\ lesion\\:\\ 0\\.04116293008205551\ \(0\)\
\-\ cortical\\:\\ 0\\.04109426151328322\ \(0\)\
\-\ malignant\\:\\ 0\\.040802450228052636\ \(0\)\
\-\ extension\\:\\ 0\\.04051888590113031\ \(0\)\
\-\ also\\:\\ 0\\.04038582436663968\ \(0\)\
\-\ adriamycin\\:\\ 0\\.0402573822467468\ \(0\)\
\-\ q12\\:\\ 0\\.0402573822467468\ \(0\)\
\-\ metastic\\:\\ 0\\.0394839806399873\ \(0\)\
\-\ sheets\\:\\ 0\\.0394839806399873\ \(0\)\
\-\ left\\:\\ 0\\.039051374420117156\ \(0\)\
\-\ unrevealing\\:\\ 0\\.03881402969507827\ \(0\)\
\-\ immunohistochemical\\:\\ 0\\.03881402969507827\ \(0\)\
\-\ fever\\:\\ 0\\.03880920511654287\ \(0\)\
\-\ demontrates\\:\\ 0\\.03822309108145854\ \(0\)\
\-\ mitotic\\:\\ 0\\.03822309108145854\ \(0\)\
\-\ back\\:\\ 0\\.0381747106893294\ \(0\)\
\-\ spine\\:\\ 0\\.03781242012228729\ \(0\)\
\-\ plain\\:\\ 0\\.037765088153918304\ \(0\)\
\-\ preceding\\:\\ 0\\.03769447847858137\ \(0\)\
\-\ cytoplasm\\:\\ 0\\.03769447847858137\ \(0\)\
\-\ differential\\:\\ 0\\.03719154012736171\ \(0\)\
\-\ traditionally\\:\\ 0\\.036779738529790024\ \(0\)\
\-\ erythrocyte\\:\\ 0\\.03637814991017793\ \(0\)\
\-\ characterization\\:\\ 0\\.03600633692303052\ \(0\)\
\-\ cycles\\:\\ 0\\.035660187313293124\ \(0\)\
\-\ cyclophosphamide\\:\\ 0\\.035660187313293124\ \(0\)\
\-\ knowledge\\:\\ 0\\.035660187313293124\ \(0\)\
\-\ primary\\:\\ 0\\.03519619928512401\ \(0\)\
\-\ neuroectodermal\\:\\ 0\\.035032221377780066\ \(0\)\
\-\ delineate\\:\\ 0\\.035032221377780066\ \(0\)\
\-\ evaluation\\:\\ 0\\.03490793935674835\ \(0\)\
\-\ pulmonary\\:\\ 0\\.0348901951280946\ \(0\)\
\-\ region\\:\\ 0\\.034238161299062056\ \(0\)\
\-\ include\\:\\ 0\\.0340570604923277\ \(0\)\
\-\ chronic\\:\\ 0\\.03397581018047446\ \(0\)\
\-\ scan\\:\\ 0\\.033959638768934264\ \(0\)\
\-\ vincristine\\:\\ 0\\.03373864649619622\ \(0\)\
\-\ hemi\\:\\ 0\\.03351562403120223\ \(0\)\
\-\ sedimentation\\:\\ 0\\.03351562403120223\ \(0\)\
\-\ centimeter\\:\\ 0\\.03330209481283324\ \(0\)\
\-\ if\\:\\ 0\\.03325764919748582\ \(0\)\
\-\ determining\\:\\ 0\\.0330972835451277\ \(0\)\
\-\ therapy\\:\\ 0\\.03288788154226367\ \(0\)\
\-\ low\\:\\ 0\\.03284441132833399\ \(0\)\
\-\ an\\:\\ 0\\.03283236527677362\ \(0\)\
\-\ history\\:\\ 0\\.03280328017007432\ \(0\)\
\-\ primitive\\:\\ 0\\.03271115619921352\ \(0\)\
\-\ accurate\\:\\ 0\\.03271115619921352\ \(0\)\
\-\ localization\\:\\ 0\\.03271115619921352\ \(0\)\
\-\ blue\\:\\ 0\\.03252869320607374\ \(0\)\
\-\ raised\\:\\ 0\\.03218254359633634\ \(0\)\
\-\ prior\\:\\ 0\\.03202567521771874\ \(0\)\
\-\ obtain\\:\\ 0\\.03201803117456124\ \(0\)\
\-\ diagnose\\:\\ 0\\.03201803117456124\ \(0\)\
\-\ both\\:\\ 0\\.03191963081000815\ \(0\)\
\-\ over\\:\\ 0\\.03182775245609871\ \(0\)\
\-\ critical\\:\\ 0\\.03155457766082329\ \(0\)\
\-\ histological\\:\\ 0\\.03155457766082329\ \(0\)\
\-\ nuclei\\:\\ 0\\.03155457766082329\ \(0\)\
\-\ metastatic\\:\\ 0\\.03139307532917186\ \(0\)\
\-\ examinations\\:\\ 0\\.031267803647544994\ \(0\)\
\-\ allows\\:\\ 0\\.031267803647544994\ \(0\)\
\-\ wing\\:\\ 0\\.03113033808018975\ \(0\)\
\-\ considering\\:\\ 0\\.030996538701776915\ \(0\)\
\-\ acute\\:\\ 0\\.03096445305565229\ \(0\)\
\-\ emergent\\:\\ 0\\.030866215027932895\ \(0\)\
\-\ palpated\\:\\ 0\\.030739191044667817\ \(0\)\
\-\ confusion\\:\\ 0\\.030615303778819342\ \(0\)\
\-\ identify\\:\\ 0\\.030494402040785486\ \(0\)\
\-\ diagnoses\\:\\ 0\\.03026100277923944\ \(0\)\
\-\ resonance\\:\\ 0\\.030037980314245448\ \(0\)\
\-\ locations\\:\\ 0\\.02993007982563371\ \(0\)\
\-\ uniform\\:\\ 0\\.02993007982563371\ \(0\)\
\-\ centered\\:\\ 0\\.029824451095876465\ \(0\)\
\-\ other\\:\\ 0\\.02972546038879891\ \(0\)\
\-\ 2cm\\:\\ 0\\.029721000434025986\ \(0\)\
\-\ avoid\\:\\ 0\\.029721000434025986\ \(0\)\
\-\ postoperative\\:\\ 0\\.029721000434025986\ \(0\)\
\-\ index\\:\\ 0\\.029619639828170917\ \(0\)\
\-\ magnetic\\:\\ 0\\.029520286495535033\ \(0\)\
\-\ mri\\:\\ 0\\.02938174869940394\ \(0\)\
\-\ manifestations\\:\\ 0\\.029327294265908688\ \(0\)\
\-\ radiography\\:\\ 0\\.029233512482256738\ \(0\)\
\-\ might\\:\\ 0\\.029233512482256738\ \(0\)\
\-\ spontaneously\\:\\ 0\\.02914145156274254\ \(0\)\
\-\ thorax\\:\\ 0\\.028962247536488666\ \(0\)\
\-\ consideration\\:\\ 0\\.028874990044190994\ \(0\)\
\-\ exam\\:\\ 0\\.02881445987776705\ \(0\)\
\-\ have\\:\\ 0\\.02859433636316935\ \(0\)\
\-\ lateral\\:\\ 0\\.028406772795865447\ \(0\)\
\-\ institution\\:\\ 0\\.028303311259767473\ \(0\)\
\-\ genetic\\:\\ 0\\.028226711613951187\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.02815126388625371\ \(0\)\
\-\ sites\\:\\ 0\\.02793149827262006\ \(0\)\
\-\ necrotic\\:\\ 0\\.02786033141493011\ \(0\)\
\-\ damage\\:\\ 0\\.02786033141493011\ \(0\)\
\-\ contrast\\:\\ 0\\.027811568984482234\ \(0\)\
\-\ differentiation\\:\\ 0\\.027790159930588212\ \(0\)\
\-\ tomography\\:\\ 0\\.027720956359694755\ \(0\)\
\-\ culture\\:\\ 0\\.027720956359694755\ \(0\)\
\-\ computed\\:\\ 0\\.02758534866288266\ \(0\)\
\-\ immediate\\:\\ 0\\.027388571310976124\ \(0\)\
\-\ tests\\:\\ 0\\.027388571310976124\ \(0\)\
\-\ depending\\:\\ 0\\.02726154732771104\ \(0\)\
\-\ population\\:\\ 0\\.027076845022173265\ \(0\)\
\-\ intense\\:\\ 0\\.02701675832382871\ \(0\)\
\-\ better\\:\\ 0\\.02701675832382871\ \(0\)\
\-\ called\\:\\ 0\\.026726667167061357\ \(0\)\
\-\ except\\:\\ 0\\.026670608714091312\ \(0\)\
\-\ combination\\:\\ 0\\.02656033659728867\ \(0\)\
\-\ protein\\:\\ 0\\.02656033659728867\ \(0\)\
\-\ least\\:\\ 0\\.026452436108676928\ \(0\)\
\-\ lobulated\\:\\ 0\\.026399343768323237\ \(0\)\
\-\ l5\\:\\ 0\\.026399343768323237\ \(0\)\
\-\ adult\\:\\ 0\\.026399343768323237\ \(0\)\
\-\ help\\:\\ 0\\.026294815417854195\ \(0\)\
\-\ prevent\\:\\ 0\\.02624335671706921\ \(0\)\
\-\ esr\\:\\ 0\\.02619242044866293\ \(0\)\
\-\ expansion\\:\\ 0\\.02609207351678736\ \(0\)\
\-\ which\\:\\ 0\\.026027430628861783\ \(0\)\
\-\ undergoing\\:\\ 0\\.025993694299161707\ \(0\)\
\-\ on\\:\\ 0\\.02593102749904824\ \(0\)\
\-\ appreciated\\:\\ 0\\.025802540537619115\ \(0\)\
\-\ suggesting\\:\\ 0\\.025802540537619115\ \(0\)\
\-\ spread\\:\\ 0\\.025709627153682777\ \(0\)\
\-\ containing\\:\\ 0\\.025709627153682777\ \(0\)\
\-\ highly\\:\\ 0\\.025618403197944718\ \(0\)\
\-\ pediatric\\:\\ 0\\.025618403197944718\ \(0\)\
\-\ atelectasis\\:\\ 0\\.025484603819531885\ \(0\)\
\-\ fevers\\:\\ 0\\.025269241171818755\ \(0\)\
\-\ dyspnea\\:\\ 0\\.025185619580357383\ \(0\)\
\-\ felt\\:\\ 0\\.025144325690095292\ \(0\)\
\-\ opacity\\:\\ 0\\.024903454827251165\ \(0\)\
\-\ injection\\:\\ 0\\.024903454827251165\ \(0\)\
\-\ local\\:\\ 0\\.02463631754880306\ \(0\)\
\-\ origin\\:\\ 0\\.02463631754880306\ \(0\)\
\-\ require\\:\\ 0\\.024599290226909733\ \(0\)\
\-\ short\\:\\ 0\\.024599290226909733\ \(0\)\
\-\ evaluated\\:\\ 0\\.024453854555663283\ \(0\)\
\-\ department\\:\\ 0\\.024209065551780953\ \(0\)\
\-\ adenopathy\\:\\ 0\\.024074368083444587\ \(0\)\
\-\ reveal\\:\\ 0\\.024074368083444587\ \(0\)\
\-\ their\\:\\ 0\\.02375264382524091\ \(0\)\
\-\ 36\\:\\ 0\\.023690702552763523\ \(0\)\
\-\ cavity\\:\\ 0\\.023629516680497512\ \(0\)\
\-\ count\\:\\ 0\\.023629516680497512\ \(0\)\
\-\ young\\:\\ 0\\.023599201305216488\ \(0\)\
\-\ affected\\:\\ 0\\.02353911460687193\ \(0\)\
\-\ indicated\\:\\ 0\\.02353911460687193\ \(0\)\
\-\ neurological\\:\\ 0\\.02350933897440725\ \(0\)\
\-\ suspected\\:\\ 0\\.023450312654243632\ \(0\)\
\-\ normal\\:\\ 0\\.02337055834302334\ \(0\)\
\-\ suggestive\\:\\ 0\\.023305715345325884\ \(0\)\
\-\ four\\:\\ 0\\.02319296499713453\ \(0\)\
\-\ rupture\\:\\ 0\\.02313752598725984\ \(0\)\
\-\ best\\:\\ 0\\.02302845257535943\ \(0\)\
\-\ shortness\\:\\ 0\\.022948175993252204\ \(0\)\
\-\ us\\:\\ 0\\.022765713000112427\ \(0\)\
\-\ from\\:\\ 0\\.02273315551589617\ \(0\)\
\-\ formation\\:\\ 0\\.02268950121555755\ \(0\)\
\-\ films\\:\\ 0\\.02266435239425736\ \(0\)\
\-\ same\\:\\ 0\\.022639329004008675\ \(0\)\
\-\ not\\:\\ 0\\.02259684551700888\ \(0\)\
\-\ occurs\\:\\ 0\\.022564999061621478\ \(0\)\
\-\ many\\:\\ 0\\.022564999061621478\ \(0\)\
\-\ 22\\:\\ 0\\.022540465128408883\ \(0\)\
\-\ presenting\\:\\ 0\\.022419563390375034\ \(0\)\
\-\ pelvic\\:\\ 0\\.022372006831995136\ \(0\)\
\-\ results\\:\\ 0\\.022301506664804387\ \(0\)\
\-\ cells\\:\\ 0\\.022051164611827857\ \(0\)\
\-\ uptake\\:\\ 0\\.022006960102575107\ \(0\)\
\-\ currently\\:\\ 0\\.0219850030463295\ \(0\)\
\-\ progressive\\:\\ 0\\.02191970261027744\ \(0\)\
\-\ vertebral\\:\\ 0\\.02185524117522325\ \(0\)\
\-\ reveals\\:\\ 0\\.021770561032662006\ \(0\)\
\-\ rate\\:\\ 0\\.021687286434723455\ \(0\)\
\-\ subsequent\\:\\ 0\\.02166668197313851\ \(0\)\
\-\ previous\\:\\ 0\\.021625725179617528\ \(0\)\
\-\ rare\\:\\ 0\\.021605371482963015\ \(0\)\
\-\ structures\\:\\ 0\\.02150482344158368\ \(0\)\
\-\ used\\:\\ 0\\.021425811110294388\ \(0\)\
\-\ 11\\:\\ 0\\.021425811110294388\ \(0\)\
\-\ second\\:\\ 0\\.021425811110294388\ \(0\)\
\-\ thoracic\\:\\ 0\\.02138676671601304\ \(0\)\
\-\ emergency\\:\\ 0\\.021233558495815603\ \(0\)\
\-\ commonly\\:\\ 0\\.021177290474150456\ \(0\)\
\-\ occur\\:\\ 0\\.021048401715043637\ \(0\)\
\-\ breath\\:\\ 0\\.020976210838706506\ \(0\)\
\-\ metastasis\\:\\ 0\\.020976210838706506\ \(0\)\
\-\ abnormality\\:\\ 0\\.02081748190961152\ \(0\)\
\-\ laboratory\\:\\ 0\\.02078288053560916\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.020714385555825485\ \(0\)\
\-\ involvement\\:\\ 0\\.020714385555825485\ \(0\)\
\-\ presence\\:\\ 0\\.020563607550906585\ \(0\)\
\-\ very\\:\\ 0\\.02053070789633322\ \(0\)\
\-\ including\\:\\ 0\\.020481759416916673\ \(0\)\
\-\ portion\\:\\ 0\\.020465548807194006\ \(0\)\
\-\ nerve\\:\\ 0\\.020417228889460116\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02032196312835216\ \(0\)\
\-\ identified\\:\\ 0\\.02029060565537408\ \(0\)\
\-\ obtained\\:\\ 0\\.020243933883054926\ \(0\)\
\-\ palpable\\:\\ 0\\.02010646831569969\ \(0\)\
\-\ effect\\:\\ 0\\.02007642523584325\ \(0\)\
\-\ biopsy\\:\\ 0\\.020061470889915153\ \(0\)\
\-\ complete\\:\\ 0\\.020061470889915153\ \(0\)\
\-\ location\\:\\ 0\\.019928850498546737\ \(0\)\
\-\ side\\:\\ 0\\.0197713797331478\ \(0\)\
\-\ presentation\\:\\ 0\\.019701403991518783\ \(0\)\
\-\ benign\\:\\ 0\\.01965988227030306\ \(0\)\
\-\ areas\\:\\ 0\\.01943087057295831\ \(0\)\
\-\ first\\:\\ 0\\.019313732660565665\ \(0\)\
\-\ week\\:\\ 0\\.019249818683566955\ \(0\)\
\-\ three\\:\\ 0\\.01921185749860077\ \(0\)\
\-\ initial\\:\\ 0\\.01919926733052735\ \(0\)\
\-\ study\\:\\ 0\\.0190873553446647\ \(0\)\
\-\ radiation\\:\\ 0\\.018965868068981304\ \(0\)\
\-\ positive\\:\\ 0\\.018858989201090755\ \(0\)\
\-\ body\\:\\ 0\\.018835544395137283\ \(0\)\
\-\ out\\:\\ 0\\.01881220863518699\ \(0\)\
\-\ several\\:\\ 0\\.01877740725164315\ \(0\)\
\-\ radiograph\\:\\ 0\\.018640566605425225\ \(0\)\
\-\ past\\:\\ 0\\.018629329916866184\ \(0\)\
\-\ no\\:\\ 0\\.018613677334713002\ \(0\)\
\-\ adjacent\\:\\ 0\\.018551369956707007\ \(0\)\
\-\ area\\:\\ 0\\.01854033105380616\ \(0\)\
\-\ any\\:\\ 0\\.018496416731044973\ \(0\)\
\-\ such\\:\\ 0\\.018409724650292888\ \(0\)\
\-\ approximately\\:\\ 0\\.01826152714441907\ \(0\)\
\-\ medical\\:\\ 0\\.018189038256181733\ \(0\)\
\-\ clinical\\:\\ 0\\.01813789429297923\ \(0\)\
\-\ only\\:\\ 0\\.017880037819953218\ \(0\)\
\-\ years\\:\\ 0\\.017543564547534262\ \(0\)\
\-\ month\\:\\ 0\\.01740976516912143\ \(0\)\
\-\ level\\:\\ 0\\.017288025208824425\ \(0\)\
\-\ when\\:\\ 0\\.017288025208824425\ \(0\)\
\-\ appearance\\:\\ 0\\.017253778117867397\ \(0\)\
\-\ likely\\:\\ 0\\.01710249491758555\ \(0\)\
\-\ two\\:\\ 0\\.016996003847999704\ \(0\)\
\-\ time\\:\\ 0\\.016963686961100045\ \(0\)\
\-\ however\\:\\ 0\\.016939585172503338\ \(0\)\
\-\ presented\\:\\ 0\\.01668945590271562\ \(0\)\
\-\ been\\:\\ 0\\.01667422924658395\ \(0\)\
\-\ lobe\\:\\ 0\\.016539229729582827\ \(0\)\
\-\ significant\\:\\ 0\\.016524451576499274\ \(0\)\
\-\ due\\:\\ 0\\.01645120678158996\ \(0\)\
\-\ cm\\:\\ 0\\.01643668526828469\ \(0\)\
\-\ lesions\\:\\ 0\\.01643668526828469\ \(0\)\
\-\ high\\:\\ 0\\.016265628495370006\ \(0\)\
\-\ more\\:\\ 0\\.015715340357465166\ \(0\)\
\-\ physical\\:\\ 0\\.015518321498935339\ \(0\)\
\-\ into\\:\\ 0\\.015213801762911976\ \(0\)\
\-\ noted\\:\\ 0\\.015174184799694122\ \(0\)\
\-\ without\\:\\ 0\\.0150958771779143\ \(0\)\
\-\ tissue\\:\\ 0\\.015013310651714738\ \(0\)\
\-\ lower\\:\\ 0\\.014624757496811231\ \(0\)\
\-\ demonstrates\\:\\ 0\\.014378284593149902\ \(0\)\
\-\ large\\:\\ 0\\.014339948747843395\ \(0\)\
\-\ but\\:\\ 0\\.014152543979625022\ \(0\)\
\-\ findings\\:\\ 0\\.014125027387738753\ \(0\)\
\-\ surgical\\:\\ 0\\.013910164395919042\ \(0\)\
\-\ after\\:\\ 0\\.013883942144532488\ \(0\)\
\-\ male\\:\\ 0\\.012742643259201067\ \(0\)\
\-\ disease\\:\\ 0\\.012013582238115356\ \(0\)\
\-\ as\\:\\ 0\\.01149759601451087\ \(0\)\
